
Biostar Pharmaceuticals, Inc.
Action · US0906783016 (OTC)
Analyse alimentée par l’IA
Analyse fondamentale
Découvrez ce que disent vraiment les chiffres — avant le marché
Analyser maintenant
Sentiment des actualités
Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?
Analyser maintenant
Acheter / Conserver / Vendre
Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.
Analyser maintenant
Évaluation des risques
Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.
Analyser maintenant
Juste valeur
Cette action est-elle bon marché, correctement valorisée ou surévaluée ?
Analyser maintenant
Dernières analyses d’IA sur Biostar Pharmaceuticals, Inc.
Pas de cours
Cours de clôture OTC 28.04.2026:
0,0001 USD
28.04.2026 20:00
Cours actuels de Biostar Pharmaceuticals, Inc.
| Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
|---|---|---|---|---|---|
UTC |
BSPM
|
USD
|
28.04.2026 20:00
|
0,0001 USD
| 0,00 USD |
Profil de l'entreprise pour Biostar Pharmaceuticals, Inc. Action
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Données de l'entreprise
Nom Biostar Pharmaceuticals, Inc.
Société Biostar Pharmaceuticals, Inc.
Site web
https://biostarpharmaceuticals.com
Marché d'origine
UTC
ISIN US0906783016
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - Specialty & Generic
PDG Ronghua Wang
Pays Chine
Devise USD
Employés 0,2 T
Adresse No. 588 Shiji Xi Road, 712000 Xianyang
Date d'introduction en bourse 2008-12-18
Fractionnements d'actions
| Date | Fractionnement |
|---|---|
| 05.02.2016 | 1:7 |
| 04.04.2012 | 1:3 |
Symboles boursiers
| Nom | Symbole |
|---|---|
| Over The Counter | BSPM |
Autres actions
Les investisseurs qui détiennent Biostar Pharmaceuticals, Inc. ont également les actions suivantes dans leur portefeuille :
